Literature DB >> 24863884

Feasibility study of CT perfusion imaging for prostate carcinoma.

Nesat Cullu1, Mecit Kantarci, Hayri Ogul, Senol Adanur, Aylin Okur, Erdem Koc, Berhan Pirimoglu, Leyla Karaca, Yesim Kizrak, Ozkan Polat.   

Abstract

OBJECTIVE: The aim of this feasibility study was to obtain initial data with which to assess the efficiency of perfusion CT imaging (CTpI) and to compare this with magnetic resonance imaging (MRI) in the diagnosis of prostate carcinoma.
MATERIALS AND METHODS: This prospective study involved 25 patients with prostate carcinoma undergoing MRI and CTpI. All analyses were performed on T2-weighted images (T2WI), apparent diffusion coefficient (ADC) maps, diffusion-weighted images (DWI) and CTp images. We compared the performance of T2WI combined with DWI and CTp alone. The study was approved by the local ethics committee, and written informed consent was obtained from all patients.
RESULTS: Tumours were present in 87 areas according to the histopathological results. The diagnostic performance of the T2WI+DWI+CTpI combination was significantly better than that of T2WI alone for prostate carcinoma (P < 0.001). The diagnostic value of CTpI was similar to that of T2WI+DWI in combination. There were statistically significant differences in the blood flow and permeability surface values between prostate carcinoma and background prostate on CTp images.
CONCLUSION: CTp may be a valuable tool for detecting prostate carcinoma and may be preferred in cases where MRI is contraindicated. If this technique is combined with T2WI and DWI, its diagnostic value is enhanced. KEY POINTS: Perfusion CT is a helpful technique for prostate carcinoma diagnosis. •Colour maps allow easy and rapid visual assessment of the functional changes. Colour maps of prostate carcinoma provide information about in vivo tumoral vascularity. CTp images may be added into routine radiological examinations. CTp provides guidance for histopathological correlation if biopsy is scheduled.

Entities:  

Mesh:

Year:  2014        PMID: 24863884     DOI: 10.1007/s00330-014-3212-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

Review 1.  Perfusion CT: a worthwhile enhancement?

Authors:  K A Miles; M R Griffiths
Journal:  Br J Radiol       Date:  2003-04       Impact factor: 3.039

Review 2.  Local staging of prostate cancer with MRI.

Authors:  Fatma Nur Soylu; Scott Eggener; Aytekin Oto
Journal:  Diagn Interv Radiol       Date:  2012-03-08       Impact factor: 2.630

3.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.

Authors:  Michael Mullerad; Hedvig Hricak; Kentaro Kuroiwa; Darko Pucar; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

4.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Leena M Hamberg; Peter F Hahn; Christopher G Willett; Sanjay Saini; Peter R Mueller; Ting-Yim Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

5.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.

Authors:  Huadong Miao; Hiroshi Fukatsu; Takeo Ishigaki
Journal:  Eur J Radiol       Date:  2006-11-07       Impact factor: 3.528

6.  Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.

Authors:  M Chen; H-D Dang; J-Y Wang; C Zhou; S-Y Li; W-C Wang; W-F Zhao; Z-H Yang; C-Y Zhong; G-Z Li
Journal:  Acta Radiol       Date:  2008-06       Impact factor: 1.990

7.  Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

Authors:  Andreas Erbersdobler; Hendrik Isbarn; Kira Dix; Isabel Steiner; Thorsten Schlomm; Martina Mirlacher; Guido Sauter; Alexander Haese
Journal:  World J Urol       Date:  2009-08-28       Impact factor: 4.226

Review 8.  VEGF inhibitors and prostate cancer therapy.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339

Review 9.  Angiogenesis imaging in the management of prostate cancer.

Authors:  Anwar R Padhani; Christopher J Harvey; David O Cosgrove
Journal:  Nat Clin Pract Urol       Date:  2005-12

Review 10.  Perfusion imaging with computed tomography: brain and beyond.

Authors:  Kenneth A Miles
Journal:  Eur Radiol       Date:  2006-11       Impact factor: 5.315

View more
  1 in total

1.  Can Computed Tomography Perfusion Predict Treatment Response After Prostate Artery Embolization: A Feasibility Study.

Authors:  Brian Malling; Martin Andreas Røder; Carsten Lauridsen; Lars Lönn
Journal:  Diagnostics (Basel)       Date:  2020-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.